We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORGN
2926
DELISTED
Origin Materials
ORGN
$15K ﹤0.01%
952
GCTS.WS
2927
GCT Semiconductor Holding Warrants
GCTS.WS
$18.4M
$15K ﹤0.01%
37,675
WGSWW
2928
DELISTED
GeneDx Holdings Warrant
WGSWW
$14K ﹤0.01%
250,930
FUV
2929
DELISTED
Arcimoto, Inc. Common Stock
FUV
$13K ﹤0.01%
26,725
VLD
2930
DELISTED
Velo3D, Inc.
VLD
$12K ﹤0.01%
711
+60
+9% +$677
HYPD
2931
Hyperion DeFi Inc
HYPD
$40.8M
$11K ﹤0.01%
+134
New +$18.2K
AKTS
2932
DELISTED
Akoustis Technologies Inc
AKTS
$11K ﹤0.01%
18,463
+3,333
+22% +$2.15K
RBOT
2933
DELISTED
Vicarious Surgical
RBOT
$10K ﹤0.01%
1,027
+558
+119% +$6.66K
VATE icon
2934
INNOVATE Corp
VATE
$105M
$10K ﹤0.01%
1,414
TVRD
2935
Tvardi Therapeutics
TVRD
$22.1M
$10K ﹤0.01%
290
FOA icon
2936
Finance of America Companies
FOA
$203M
$9K ﹤0.01%
1,175
SOAR.WS
2937
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$9K ﹤0.01%
55,375
BKKT icon
2938
Bakkt Inc
BKKT
$336M
$8K ﹤0.01%
655
BHIL
2939
DELISTED
Benson Hill, Inc.
BHIL
$8K ﹤0.01%
1,041
CSSE
2940
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$7K ﹤0.01%
39,100
VSTEW
2941
DELISTED
Vast Renewables Limited Warrants
VSTEW
$4K ﹤0.01%
38,375
BGXX
2942
DELISTED
Bright Green Corporation Common Stock
BGXX
$3K ﹤0.01%
12,206
CMCAW
2943
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$3K ﹤0.01%
55,375
RCFA.WS
2944
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$3K ﹤0.01%
37,850
BFAC.WS
2945
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$2K ﹤0.01%
55,855
ONYXW
2946
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$2K ﹤0.01%
37,750
AEVA
2947
Aeva Technologies
AEVA
$1.75B
-28,354
Closed -$108K
ANTX icon
2948
AN2 Therapeutics
ANTX
$237M
-187,399
Closed -$3.84M
ATLC icon
2949
Atlanticus Holdings
ATLC
$1.48B
-5,268
Closed -$204K
BTG icon
2950
B2Gold
BTG
$6.88B
-7,474,972
Closed -$23.6M

Similar funds

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.